A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy, Safety and Tolerability of Tegaserod 2 mg Bid vs Placebo in Patients With Chronic Constipation
Clinical trial NCT00563758 · TERMINATED
Trial details
- NCT number
- NCT00563758
- Sponsor
- Hospital Authority, Hong Kong
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.